APA (7th ed.) Citation

J, C., JE, G., Y, C., Y, O., F, I., BC, C., . . . SS, R. (2023). Author Correction: Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer. Nature communications, 14(1), 3179. https://doi.org/10.1038/s41467-023-38999-0

Chicago Style (17th ed.) Citation

J, Chmielecki, et al. "Author Correction: Candidate Mechanisms of Acquired Resistance to First-line Osimertinib in EGFR-mutated Advanced Non-small Cell Lung Cancer." Nature Communications 14, no. 1 (2023): 3179. https://doi.org/10.1038/s41467-023-38999-0.

MLA (9th ed.) Citation

J, Chmielecki, et al. "Author Correction: Candidate Mechanisms of Acquired Resistance to First-line Osimertinib in EGFR-mutated Advanced Non-small Cell Lung Cancer." Nature Communications, vol. 14, no. 1, 2023, p. 3179, https://doi.org/10.1038/s41467-023-38999-0.